 Krystal Fontaine
|
|
| Title | Postdoctoral Scholar |
|---|
| Institution | University of California San Francisco |
|---|
| Department | Gladstone Institutes |
|---|
| Address | |
|---|
| vCard | Download vCard |
|---|
|
|
 Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
Researchers can login to make corrections and additions, or contact us for help.
-
Khan S, Woodruff EM, Trapecar M, Fontaine KA, Ezaki A, Borbet TC, Ott M, Sanjabi S. Dampened antiviral immunity to intravaginal exposure to RNA viral pathogens allows enhanced viral replication. J Exp Med. 2016 Dec 12; 213(13):2913-2929. PMID: 27852793.
-
Meyers NL, Fontaine KA, Kumar GR, Ott M. Entangled in a membranous web: ER and lipid droplet reorganization during hepatitis C virus infection. Curr Opin Cell Biol. 2016 08; 41:117-24. PMID: 27240021.
-
Fontaine KA, Sanchez EL, Camarda R, Lagunoff M. Dengue virus induces and requires glycolysis for optimal replication. J Virol. 2015 Feb; 89(4):2358-66. PMID: 25505078; PMCID: PMC4338897.
-
Fontaine KA, Camarda R, Lagunoff M. Vaccinia virus requires glutamine but not glucose for efficient replication. J Virol. 2014 Apr; 88(8):4366-74. PMID: 24501408; PMCID: PMC3993723.
-
Lok SM, Costin JM, Hrobowski YM, Hoffmann AR, Rowe DK, Kukkaro P, Holdaway H, Chipman P, Fontaine KA, Holbrook MR, Garry RF, Kostyuchenko V, Wimley WC, Isern S, Rossmann MG, Michael SF. Release of dengue virus genome induced by a peptide inhibitor. PLoS One. 2012; 7(11):e50995. PMID: 23226444; PMCID: PMC3511436.
-
Costin JM, Jenwitheesuk E, Lok SM, Hunsperger E, Conrads KA, Fontaine KA, Rees CR, Rossmann MG, Isern S, Samudrala R, Michael SF. Structural optimization and de novo design of dengue virus entry inhibitory peptides. PLoS Negl Trop Dis. 2010 Jun 22; 4(6):e721. PMID: 20582308; PMCID: PMC2889824.
-
Schieffelin JS, Costin JM, Nicholson CO, Orgeron NM, Fontaine KA, Isern S, Michael SF, Robinson JE. Neutralizing and non-neutralizing monoclonal antibodies against dengue virus E protein derived from a naturally infected patient. Virol J. 2010 Feb 04; 7:28. PMID: 20132551; PMCID: PMC2829534.
-
Rees CR, Costin JM, Fink RC, McMichael M, Fontaine KA, Isern S, Michael SF. In vitro inhibition of dengue virus entry by p-sulfoxy-cinnamic acid and structurally related combinatorial chemistries. Antiviral Res. 2008 Nov; 80(2):135-42. PMID: 18606464.
|
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Related Authors People who share related concepts with this person. _
|